Research & Publications †
( † Disclaimer: This search is powered by PubMed, a service of the U.S. National Library of Medicine. PubMed is a third-party website with no affiliation with Cleveland Clinic.)
Mark Angel, MD, is an interventional cardiologist in the Robert and Suzanne Tomsich Department of Cardiovascular Medicine in the Sydell and Arnold Miller Family Heart & Vascular Institute. He practices at Cleveland Clinic Fairview and Lakewood hospitals and the Richard E. Jacobs Health Center in Avon, Ohio.
Dr. Angel is board-certified in cardiovascular disease and interventional cardiology. His specialty is the non-surgical treatment of coronary artery disease, with particular emphasis on complex coronary intervention using radial artery based access.
Before his appointment to the Cleveland Clinic staff in 2012, Dr. Angel was in practice with Cardiovascular and Interventional Associates in Akron, Ohio, where he has been since 2008. Before joining that practice, he was with Cardiovascular Consultants of Cleveland in Willoughby, Ohio for 14 years.
A South Africa native, Dr. Angel received a Bachelor of Medicine and Bachelor of Surgery (MBBCh) degree from the University of Witwatersrand, Johannesburg, South Africa. He completed residencies in cardiology, cardiac intensive care and nephrology at J.G. Strijdom Hospital in Johannesburg.
After relocating to the United States in 1987, Dr. Angel continued his training with a residency in internal medicine at Mt. Sinai Hospital, Chicago followed by fellowships in clinical cardiology at Vanderbilt University Medical Center, Nashville, Tenn., and in Interventional Cardiology at the University of Virginia Health Sciences Center, Charlottesville, Va.
Dr. Angel is a member of the American College of Physicians and a Fellow of the American College of Cardiology.
Coronary artery disease, heart attack, stent restenosis, total coronary occlusions, coronary stent, cardiac catheterization, FFR determination, cardiologist
Cleveland Clinic physicians and scientists may collaborate with the pharmaceutical or medical device industries to help develop medical breakthroughs or provide medical expertise or education. Cleveland Clinic strives to make scientific advances that will benefit patient care and support outside relationships that promise public benefit. In order for the discoveries of Cleveland Clinic physicians' and scientists' laboratories and investigations to benefit the public, these discoveries must be commercialized in partnership with industry. As experts in their fields, Cleveland Clinic physicians and scientists are often sought after by industry to consult, provide expertise and education.
To assure professional and commercial integrity in such matters, Cleveland Clinic maintains a program that reviews these collaborations and, when appropriate, puts measures in place to minimize bias that may result from ties to industry. The Cleveland Clinic publicly discloses the names of companies when (i) its physicians/scientists receive $5,000 or more per year (or, in rare cases, equity or stock options) for speaking and consulting, (ii) its physicians/scientists serve as a fiduciary, (iii) its physicians/scientists
receive or have the right to receive royalties or (iv) its physicians/scientists hold any equity interest for the physician's/scientist's role as inventor, discoverer, developer, founder or consultant.* In publicly disclosing this information, the Cleveland Clinic tries to provide information as accurately as possible about its physicians' and scientists' connections with industry.
As of 4/8/2015, Dr. Angel has reported no financial relationship with industry that is applicable to this listing. In general, patients should feel free to contact their doctor about any of the relationships and how the relationships are overseen by the Cleveland Clinic. To learn more about the Cleveland Clinic's policies on collaborations with industry and innovation management, go to our Integrity in Innovation page.
Public Health Service-Reportable Financial Conflicts of Interest. Cleveland Clinic scientists and physicians engage in basic, translational and clinical research activities, working to solve health problems, enhance patient care and improve quality of life for patients. Interactions with industry are essential to bringing the researchers’ discoveries to the public, but can present the potential for conflicts of interest related to their research activities. Click here to view a listing of instances where Cleveland Clinic has identified a Public Health Service (PHS)-Reportable Financial Conflict of Interest and has put measures in place to ensure that, to the extent possible, the design, conduct and reporting of the research is free from bias. * Cleveland Clinic physicians and scientists subscribe to the guidance presented in the PhRMA Code on Interactions with Healthcare Professionals and the AdvaMed Code of Ethics on Interactions with Health Care Professionals. As such, gifts of substantial value are generally prohibited.